The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25
Abstract
In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al . in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2–cyclin B complex and mitotic entry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The phosphorylation of Chk1 enhances Chk1’s kinase activity, which in turn phosphorylates downstream substrates (e.g., Cdc25, BLM, and FANCD2/FANCE) and facilitates cell cycle arrest and DNA damage repair [91–93].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [91]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Self-citationRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242
Wodarz, A., Hinz, U., Engelbert, M., & Knust, E. (1995) · Cell · doi:10.1016/0092-8674(95)90053-5 · Cited by 661
Enoch, T., & Nurse, P. (1990) · Cell · doi:10.1016/0092-8674(90)90669-6 · Cited by 460
Fission yeast chkl protein kinase links the rad checkpoint pathway to cdc2
Walworth, N. C., Davey, S. K., & Beach, D. (1993) · Nature · doi:10.1038/363368a0 · Cited by 455
Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation
O’Connell, M. J., Raleigh, J., Verkade, H. M., & Nurse, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.545 · Cited by 398
rad -Dependent Response of the chk1 -Encoded Protein Kinase at the DNA Damage Checkpoint
Walworth, N. C., & Bernards, R. (1996) · Science · doi:10.1126/science.271.5247.353 · Cited by 397
Flagged first, then by citations
Research works printed but not linked: 3
- Waldman T., et al., ibid. 381, 713 (1996).
- Vorechovsky I., et al., Cancer Res. 56, 2726 (1996);
- Lakin N. D., et al., Oncogene 13, 2707 (1996).
Cited by
Sorted by citations
Items 201–300 of 1,000
Cortes-Bratti, X., Karlsson, C., Lagergård, T., Thelestam, M., & Frisan, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008527200 · Cited by 162
The G2 DNA damage checkpoint targets both Wee1 and Cdc25
Raleigh, J., & O’Connell, M. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1727 · Cited by 162
Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses
Martinho, R. G., Lindsay, H. D., Flaggs, G., DeMaggio, A. J., Hoekstra, M. F., Carr, A. M., & Bentley, N. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7239 · Cited by 161
Fabbro, M., Savage, K. I., Hobson, K., Deans, A. J., Powell, S. N., McArthur, G. A., & Khanna, K. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405372200 · Cited by 169
Cdc14: a highly conserved family of phosphatases with non-conserved functions?
Mocciaro, A., & Schiebel, E. (2010) · Journal of Cell Science · doi:10.1242/jcs.074815 · Cited by 160
Zeng, Y., & Piwnica-Worms, H. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7410 · Cited by 157
Self-citationHuman Claspin works with BRCA1 to both positively and negatively regulate cell proliferation
Lin, S.-Y., Li, K., Stewart, G. S., & Elledge, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401847101 · Cited by 156
Self-citationLi, X., Wang, G., Zhao, J., Ding, H., Cunningham, C., Chen, F., Flynn, D. C., Reed, E., & Li, Q. Q. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5027-1 · Cited by 155
Bahassi, E. M., Conn, C. W., Myer, D. L., Hennigan, R. F., McGowan, C. H., Sánchez, Y., & Stambrook, P. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205850 · Cited by 155
The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
Jallepalli, P. V., Lengauer, C., Vogelstein, B., & Bunz, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213159200 · Cited by 154
Polo-like Kinase 1 and Chk2 Interact and Co-localize to Centrosomes and the Midbody
Tsvetkov, L. M., Xu, X., Li, J., & Stern, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211202200 · Cited by 156
Kytölä, S. I., Höög, A., Nord, B., Cedermark, B., Frisk, T., Larsson, C., & Kjellman, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64136-3 · Cited by 154
Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation
Moon, D.-O., Kim, M.-O., Choi, Y. H., Hyun, J. W., Chang, W. Y., & Kim, G.-Y. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.07.002 · Cited by 151
Hirose, Y., Katayama, M., Mirzoeva, O. K., Berger, M. S., & Pieper, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2633 · Cited by 151
A DNA damage and stress inducible G protein-coupled receptor blocks cells in G 2 /M
Weng, Z., Fluckiger, A.-C., Nisitani, S., Wahl, M. I., Le, L. Q., Hunter, C. A., Fernal, A. A., Beau, M. M. L., & Witte, O. N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12334 · Cited by 151
Cell cycle-dependent and ATM-independent expression of human Chk1 kinase
Kaneko, Y., Watanabe, N., Morisaki, H., Akita, H., Fujimoto, A., Tominaga, K., Terasawa, M., Tachibana, A., Ikeda, K., & Nakanishi, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202706 · Cited by 150
PP1 control of M phase entry exerted through 14‐3‐3‐regulated Cdc25 dephosphorylation
Margolis, S. S., Walsh, S., Weiser, D. C., Yoshida, M., Shenolikar, S., & Kornbluth, S. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg545 · Cited by 149
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 154
Huang, X., Tran, T. T., Zhang, L., Hatcher, R. J., & Zhang, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409130102 · Cited by 150
Breaking Bad: How Viruses Subvert the Cell Cycle
Fan, Y., Sanyal, S., & Bruzzone, R. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00396 · Cited by 150
Bachmann, M., Hennemann, H., Xing, P., Hoffmann, I., & Möröy, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404440200 · Cited by 147
Lee, C. H., & Chung, J. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104414200 · Cited by 149
Cortez, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307088200 · Cited by 149
Jiang, K., Pereira, E., Maxfield, M. D., Russell, B., Goudelock, D. M., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300070200 · Cited by 147
Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest
Capasso, H., Palermo, C., Wan, S., Rao, H., John, U. P., O’Connell, M. J., & Walworth, N. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.00133 · Cited by 150
Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway
Wang, X., Kennedy, R. D., Ray, K., Stuckert, P., Ellenberger, T., & D’Andrea, A. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02357-06 · Cited by 147
Ishida, S., Fukazawa, J., Yuasa, T., & Takahashi, Y. (2004) · The Plant Cell · doi:10.1105/tpc.104.024604 · Cited by 145
Pds1 phosphorylation in response to DNA damage is essential for its DNA damage checkpoint functionPreprint
Wang, H., Liu, D., Wang, Y., Qin, J., & Elledge, S. J. (2001) · Genes & Development · doi:10.1101/gad.893201 · Cited by 143
Self-citationChoi, H. J. C., Lin, J., Vannier, J., Slaats, G. G. G., Kile, A. C., Paulsen, R. D., Manning, D. K., Beier, D. R., Giles, R. H., Boulton, S. J., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.006 · Cited by 149
Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
Yih, L., & Lee, T. (2000) · PubMed · Cited by 142
Burtelow, M. A., Roos‐Mattjus, P., Rauen, M. P., Babendure, J. R., & Karnitz, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102946200 · Cited by 142
Kaelin, W. G. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.594 · Cited by 143
St.Onge, R. P., Udell, C. M., Casselman, R., & Davey, S. K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.6.1985 · Cited by 141
Shi, Z., Azuma, A., Sampath, D., Li, Y., Huang, P., & Plunkett, W. K. (2001) · PubMed · Cited by 139
O'Neill, T. B., Giarratani, L., Chen, P., Iyer, L. K., Lee, C. H., Bobiak, M., Kanai, F., Zhou, B. S., Chung, J. H., & Rathbun, G. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111705200 · Cited by 139
Control of Swe1p degradation by the morphogenesis checkpoint
Sia, R. A. L., Bardes, E. S. G., & Lew, D. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6678 · Cited by 139
Patel, R., Holt, M., Philipova, R., Moss, S. J., Schulman, H., Hidaka, H., & Whitaker, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7958 · Cited by 139
Dual-specificity phosphatases as targets for antineoplastic agents
Lyon, M. A., Ducruet, A. P., Wipf, P., & Lazo, J. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd963 · Cited by 139
Yu, Q., Rose, J. H. L., Zhang, H., Takemura, H., Kohn, K. W., & Pommier, Y. G. (2002) · PubMed · Cited by 138
Hu, B., Mitra, J., van den Heuvel, S., & Enders, G. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2755-2766.2001 · Cited by 136
Lavin, M. F. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 137
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Uto, K., Inoue, D., Shimuta, K., Nakajo, N., & Sagata, N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600328 · Cited by 134
Targeting DNA repair pathway in cancer: Mechanisms and clinical application
Wang, M., Chen, S., & Ao, D. (2021) · MedComm · doi:10.1002/mco2.103 · Cited by 140
Rad18 Is Required for DNA Repair and Checkpoint Responses in Fission Yeast
Verkade, H. M., Bugg, S. J., Lindsay, H. D., Carr, A. M., & O’Connell, M. J. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.9.2905 · Cited by 134
Ultrasensitivity in the Regulation of Cdc25C by Cdk1
Trunnell, N. B., Poon, A. C., Kim, S. Y., & Ferrell, J. E. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.012 · Cited by 132
Matthews, D. J., Yakes, M., Chen, J., Tadano, M., Bornheim, L. M., Clary, D. O., Tai, A., Wagner, J. M., Miller, N., Kim, Y. D., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3699 · Cited by 134
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
Bertoni, F., Codegoni, A. M., Furlan, D., Tibiletti, M. G., Capella, C., & Broggini, M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199910)26:2 · Cited by 132
CDC25B Phosphorylation by Aurora A Occurs at the G2/M Transition and is Inhibited by DNA Damage
Cazalès, M., Schmitt, E., Montembault, É., Dozier, C., Prigent, C., & Ducommun, B. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1964 · Cited by 131
Progress towards a clinically-successful ATR inhibitor for cancer therapy
Barnieh, F. M., Loadman, P. M., & Falconer, R. A. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100017 · Cited by 134
Vanadate-Induced Cell Growth Regulation and the Role of Reactive Oxygen Species
Zhang, Z., Huang, C., Li, J., Leonard, S. S., Lanciotti, R. S., Butterworth, L. F., & Shi, X. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2464 · Cited by 130
DNA repair in mammalian embryos
Jaroudi, S., & SenGupta, S. B. (2006) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.09.002 · Cited by 131
Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics
Chen, Z., Xiao, Z., Gu, W., Xue, J., Bui, M. H., Kovar, P. J., Li, G., Wang, G., Tao, Z., Tong, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22198 · Cited by 129
Cortes-Bratti, X., Chaves‐Olarte, E., Lagergård, T., & Thelestam, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3831 · Cited by 128
Eukaryotic DNA damage checkpoint activation in response to double-strand breaks
Finn, K., Lowndes, N. F., & Grenon, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0875-3 · Cited by 127
Replication fork dynamics and the DNA damage response
Jones, R. M., & Petermann, E. (2012) · Biochemical Journal · doi:10.1042/bj20112100 · Cited by 140
Molzan, M., Schumacher, B., Ottmann, C., Baljuls, A., Polzien, L., Weyand, M., Thiel, P., Rose, R., Rose, M., Kuhenne, P., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-09 · Cited by 131
Pichierri, P., Rosselli, F., & Franchitto, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206169 · Cited by 132
Sapkota, G. P., Deák, M., Kieloch, A., MORRICE, N. A., Goodarzi, A. A., Smythe, C., Shiloh, Y., Lees‐Miller, S. P., & Alessi, D. R. (2002) · Biochemical Journal · doi:10.1042/bj20021284 · Cited by 123
Small molecule modulators of cyclin-dependent kinases for cancer therapy
Senderowicz, A. M. (2000) · Oncogene · doi:10.1038/sj.onc.1204085 · Cited by 124
Mustelin, T. (2002) · Frontiers in bioscience · doi:10.2741/a770 · Cited by 121
Curman, D., Cinel, B., Williams, D. E., Rundle, N. T., Block, W. D., Goodarzi, A. A., Hutchins, J. R. A., Clarke, P. R., Zhou, B.-B., Lees‐Miller, S. P., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100728200 · Cited by 121
Hirose, Y., Katayama, M., Stokoe, D., Haas-Kogan, D. A., Berger, M. S., & Pieper, R. O. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8306-8315.2003 · Cited by 122
Checkpoints on the road to mitosis
Russell, P. R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01291-2 · Cited by 121
DNA replication stress and cancer chemotherapy
Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13455 · Cited by 132
Acquisition of Competence to Condense Metaphase I Chromosomes during Spermatogenesis
Cobb, J. A., Cargile, B. J., & Handel, M. A. (1999) · Developmental Biology · doi:10.1006/dbio.1998.9101 · Cited by 119
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage
Inoue, Y., Kitagawa, M., & Taya, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601652 · Cited by 119
The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 119
Chen, M.-J., Lin, Y.-T., Lieberman, H. B., Chen, G., & Lee, E. Y.-H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008871200 · Cited by 119
Jekimovs, C., Bolderson, E., Suraweera, A., Adams, M. N., O'Byrne, K. J., & Richard, D. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00086 · Cited by 123
A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells
Coats, S., Whyte, P., Fero, M. L., Lacy, S. E., Chung, G., Randel, E., Firpo, E. J., & Roberts, J. M. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80086-4 · Cited by 117
Eymin, B., Leduc, C., Coll, J., Brambilla, E. M., & Gazzéri, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206303 · Cited by 117
Comparative Analysis of Pharmacophore Screening Tools
Sanders, M. P. A., Barbosa, A. J. M., Zarzycka, B. A., Nicolaes, G. A. F., Klomp, J. P. G., de Vlieg, J., & Río, A. D. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005274 · Cited by 118
ATR, Claspin and the Rad9-Rad1-Hus1 Complex Regulate Chk1 and Cdc25A in the Absence of DNA Damage
Sørensen, C. S., Syljuåsen, R. G., Lukas, J., & Bártek, J. (2004) · Cell Cycle · doi:10.4161/cc.3.7.972 · Cited by 117
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
Association of Chk1 with 14-3-3 proteins is stimulated by DNA damagePreprint
Chen, L., Liu, T.-H., & Walworth, N. C. (1999) · Genes & Development · doi:10.1101/gad.13.6.675 · Cited by 115
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 117
Li, L., & Zou, L. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20355 · Cited by 117
Molecular targets of cancer chemoprevention by garlic-derived organosulfides
Herman-Antosiewicz, A., Powolny, A. A., & Singh, S. V. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00682.x · Cited by 114
You, Z., Kong, L., & Newport, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204120200 · Cited by 114
Regulation of CDC25B phosphatases subcellular localization
Davezac, N., Baldin, V., Gabrielli, B. G., Forrest, A. R. R., Theis‐Febvre, N., Yashida, M., & Ducommun, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203545 · Cited by 114
Burtelow, M. A., Kaufmann, S. H., & Karnitz, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001244200 · Cited by 114
Kostrub, C. F., Knudsen, K. E., Subramani, S. E., & Enoch, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2055 · Cited by 114
Lyne, P. D., Kenny, P. W., Cosgrove, D. A., Deng, C., Zabludoff, S., Wendoloski, J. J., & Ashwell, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030504i · Cited by 113
Hopkins, K. M., Auerbach, W., Wang, X. Y., Hande, M. P., Hang, H., Wolgemuth, D. J., Joyner, A. L., & Lieberman, H. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7235-7248.2004 · Cited by 114
Cdc25B activity is regulated by 14-3-3
Forrest, A. R. R., & Gabrielli, B. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204574 · Cited by 112
Johnson, N., & Shapiro, G. I. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525221 · Cited by 113
Furukawa, Y., Iwase, S., Kikuchi, J., Terui, Y., Nakamura, M., Yamada, H., Kano, Y., & Matsuda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906893199 · Cited by 111
Viallard, J.-F., Lacombe, F., Belloc, F., Pellegrin, J., & Reiffers, J. J. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(01)00087-7 · Cited by 123
Telomeric Protein Pin2/TRF1 as an Important ATM Target in Response to Double Strand DNA Breaks
Kishi, S., Zhou, X. Z., Ziv, Y., Khoo, C., HILL, D. E., Shiloh, Y., & Lu, K. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011534200 · Cited by 116
Freire, R., Murguía, J. R., Tarsounas, M., Lowndes, N. F., Møens, P. B., & Jackson, S. P. (1998) · Genes & Development · doi:10.1101/gad.12.16.2560 · Cited by 111
An overview of the KIN1/PAR‐1/MARK kinase family
Tassan, J., & Goff, X. L. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2003.10.009 · Cited by 111
G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford, B., Beljin, M., Stark, G. R., & Taylor, W. R. (2003) · PubMed · Cited by 109
Takao, N., Kato, H., Mori, R., Morrison, C. G., Sonada, E., Sun, X., Shimizu, H., Yoshioka, K., Takeda, S., & Yamamoto, K.-I. (1999) · Oncogene · doi:10.1038/sj.onc.1203172 · Cited by 109
p53-mediated protective responses to UV irradiation
Smith, M. L., & Fornace, A. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12255 · Cited by 109
Azorsa, D. O., Gonzales, I. M., Basu, G. D., Choudhary, A. K., Arora, S., Bisanz, K. M., Kiefer, J., Henderson, M. C., Trent, J. M., Hoff, D. D. V., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-43 · Cited by 108
Cell-cycle responses to DNA damage in G2
Cuddihy, A. R., & O'Connell, M. J. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(02)22013-6 · Cited by 89
A Novel CpG-free Vertebrate Insulator Silences the Testis-specific SP-10 Gene in Somatic Tissues
Abhyankar, M. M., Urekar, C., & Reddi, P. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705811200 · Cited by 108
DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system
Clarke, C., & Clarke, P. R. (2005) · Biochemical Journal · doi:10.1042/bj20041966 · Cited by 108
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 109
Basis for the Checkpoint Signal Specificity That Regulates Chk1 and Cds1 Protein Kinases
Brondello, J., Boddy, M. N., Furnari, B. A., & Russell, P. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4262 · Cited by 108
Metadata
- Authors
- Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J.
- Affiliations
- Y. Sanchez, C. Wong, S. J. Elledge, Verna and Marrs McLean Department of Biochemistry, Department of Molecular and Human Genetics, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1997-09-05
- Volume
- 277
- Issue
- 5331
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2105592350
- Cited by
- 1,320
- References
- 24
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 14 · 2023: 32 · 2022: 29 · 2021: 25 · 2020: 30 · 2019: 22 · 2018: 22 · 2017: 35 · 2016: 34 · 2015: 39 · 2014: 29 · 2013: 37 · 2012: 39
- FWCI
- 30.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32gm017763-01)
- National Institute of General Medical Sciences (GM-44664, GM17763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- Chk1, DNA damage checkpoint, Cdc25 phosphatase, cyclin-dependent kinases, cell cycle regulation, 14-3-3 protein binding, mitotic entry, protein kinases, mammalian cells
- MeSH terms
- Checkpoint Kinase 1, F-Box-WD Repeat-Containing Protein 7, Amino Acid Sequence, Animals, Chromosome Mapping, Chromosomes, Human, Pair 11, Cytoskeletal Proteins, DNA Damage, HeLa Cells, Humans, Mitosis, Molecular Sequence Data, Phosphoprotein Phosphatases, Phosphorylation, Phosphoserine, Protein Kinases, Proteins, Recombinant Fusion Proteins, Transfection, Tyrosine 3-Monooxygenase, Signal Transduction, G2 Phase, CDC2 Protein Kinase, Protein Tyrosine Phosphatases, Cell Cycle Proteins, cdc25 Phosphatases, Schizosaccharomyces pombe Proteins, Ubiquitin-Protein Ligases, F-Box Proteins, 14-3-3 Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review